Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer

• Principais autores: Hayato Yokota (Autor), Ruriko Asahi (Autor), Yumiko Akamine (Autor), Mizuki Kobayashi (Autor), Hiyu Wakabayashi (Autor), Sho Sakamoto (Autor), Yuji Okuda (Autor), Kazuhiro Sato (Autor), Katsutoshi Nakayama (Autor), Masafumi Kikuchi (Autor)
• Formato: Livro
• Publicado em: BMC, 2024-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Anamorelin, a drug to treat cancer cachexia, binds to ghrelin receptors and improves body weight and appetite. In clinical trials in Japan, patients experienced a 10.7% frequency of stimulant conduction system depression as a severe side effect. Although rare, anamorelin sometime...